发现了基于胺的新型西格玛-1受体激动剂,具有增强的选择性和安全性
Pascal Carato1, Bénédicte Oxombre1, Séverine Ravez1
1Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.
研究人员开发了针对中枢神经系统 (CNS) 疾病的西格玛-1受体 (S1R) 的新化合物. 化合物2具有较高的S1R亲和力和更高的安全性,使其成为神经退行性疾病和脑缺血治疗的有希望的候选者.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 中枢神经系统 (CNS) 疾病带来了重大的治疗挑战.
- 西格玛-1受体 (S1R) 是神经保护和神经炎症的关键点.
- 目前对中枢神经系统疾病的治疗方法有限.
研究的目的:
- 设计和合成针对S1R的新型胺衍生物.
- 为中枢神经系统应用优化连结体亲和力,选择性和安全性.
- 为进一步临床前开发确定一种化合物.
主要方法:
- 已知S1R配体 (化合物1) 的药理调节.
- 合成六种新的胺衍生物.
- 试验室试验评估S1R/S2R亲和力,ADME特性,功能活性,细胞毒性和非目标相互作用.
主要成果:
- 化合物2表现出优越的S1R亲和力和比S2R更好的选择性.
- 化合物2表现出有利的ADME特性,包括增强的透性.
- 与化合物相比,化合物2在体外心脏毒性降低,细胞毒性低.
- 功能性测试证实了关键衍生物的激素活性.
结论:
- 化合物2是一个有前途的S1R向药物候选者.
- 优化胺衍生物显示出治疗与S1R相关的中枢神经系统疾病的潜力.
- 对化合物2的进一步临床前开发是有必要的.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
12:27A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
